Cancer stem cells (CSC) can self-renew and differentiate to recapitulate the cellular heterogeneity of the original tumor [41], and Al-Hajj et al. have isolated CD44+, CD24−/low breast cancer initiating cells with CSC-like properties [42]. Here, CD44 is linked to neoplasm.